A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53

SGT-53 的 I 期开放标签安全性和药代动力学研究

• 批准号: 7719057
• 负责人: JOHN L. MARSHALL
• 金额: $ 0.14万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719057
• 关键词: Adverse event; Clinical; Computer Retrieval of Information on Scientific Projects Database; Dose; Drug Kinetics; Funding; Grant; Institution; Label; Laboratories; Phase; Physical Examination; Research; Research Personnel; Resources; Safety; Source; Testing; United States National Institutes of Health; Week

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to evaluate the safety of escalating doses of SGT-53 administered over a course of 5 weeks. Safety will be assessed by analysis of adverse experiences, clinical laboratory tests, and physical examinations.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的主要目的是评估在5周内服用的SGT-53剂量的安全性。安全将通过分析不良经验，临床实验室测试和体格检查来评估。